Zheng Quan Ri Bao Zhi Sheng·2025-12-11 10:12Core Viewpoint - The company is actively investing in innovative medical technologies, specifically in ophthalmic surgical robots and companion robots for children with autism and intellectual disabilities [1] Group 1: Investment in Medical Technology - The company has invested in a fund that supports the development of an ophthalmic surgical robot by Dishi Medical, which is designed for high-precision fundus surgeries and is currently in the clinical trial registration phase [1] - The company also participates in a fund that invests in Harbin Aiside's development of companion robots for children with autism and intellectual disabilities, which are intended to assist teachers during special education training and have completed prototype development [1]